Startseite Increase of body mass index (BMI) from 1.5 to 3 years of age augments the degree of insulin resistance corresponding to BMI at 12 years of age
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Increase of body mass index (BMI) from 1.5 to 3 years of age augments the degree of insulin resistance corresponding to BMI at 12 years of age

  • Osamu Arisaka EMAIL logo , Toshimi Sairenchi , Go Ichikawa und Satomi Koyama
Veröffentlicht/Copyright: 15. März 2017

Abstract:

To elucidate the effect of early growth patterns on the metabolic sensitivity to adiposity, we examined the relationship between the homeostatic model assessment of insulin resistance (HOMA-IR) and body mass index (BMI) levels at 12 years of age in 101 boys and 91 girls in a birth cohort. Children with an increase in BMI from the ages of 1.5 to 3 years exhibited a greater increase of HOMA-IR per BMI increase at 12 years of age compared to those with a decrease in BMI or stable BMI from 1.5 to 3 years. This suggests that children who show an increase in BMI from 1.5 to 3 years, a period normally characterized by a decreased or stable BMI, are more prone to developing insulin resistance at 12 years of age.

  1. Author contributions: Dr. Arisaka designed the study, analyzed and interpreted data, generated the table and drafted the initial manuscript; Dr. Sairenchi analyzed and interpreted data, and reviewed the manuscript; and Drs. Ichikawa and Koyama collected data and reviewed the manuscript. All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: This study was supported by a subsidy to a Grant-in-Aid for Scientific Research from the Ministry of Education, Sports, Science and Technology (Subject number: 22591136, 2010–2013, Study on early intervention of child obesity with a focus on adiposity rebound, Subject number: 25461559, 2013–2016, Exploratory/systematic cohort study to clarify the relationship between weight increase in childhood and obesity/metabolic disorder).

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Sinaiko AR, Caprio S. Insulin resistance. J Pediatr 2012;161:11–5.10.1016/j.jpeds.2012.01.012Suche in Google Scholar PubMed PubMed Central

2. Prince RL, Kuk JL, Ambler KA, Dhaliwal J, Ball GD. Predictors of metabolically healthy obesity in children. Diabetes Care 2014;37:1462–8.10.2337/dc13-1697Suche in Google Scholar PubMed

3. Nightingale CM, Rudnicka AR, Owen CG, Wells JC, Sattar N, et al. Influence of adiposity on insulin resistance and glycemia markers among U.K. Children of South Asian, black African-Caribbean, and white European origin: child heart and health study in England. Diabetes Care 2013;36:1712–9.10.2337/dc12-1726Suche in Google Scholar PubMed PubMed Central

4. Gao H, Salim A, Lee J, Tai ES, van Dam RM. Can body fat distribution, adiponectin levels and inflammation explain differences in insulin resistance between ethnic Chinese, Malays and Asian Indians? Int J Obes (Lond) 2012;36:1086–93.10.1038/ijo.2011.185Suche in Google Scholar PubMed

5. Fomon SJ, Haschke F, Ziegler EE, Nelson SE. Body composition of reference children from birth to age 10 years. Am J Clin Nutr 1982;35(Suppl 5):1169–75.10.1093/ajcn/35.5.1169Suche in Google Scholar PubMed

6. Veldhuis JD, Roemmich JN, Richmond EJ, Rogol AD, Lovejoy JC, et al. Endocrine control of body composition in infancy, childhood, and puberty. Endocr Rev 2005;26:114–46.10.1210/er.2003-0038Suche in Google Scholar PubMed

7. Toro-Ramos T, Paley C, Pi-Sunyer FX, Gallagher D. Body composition during fetal development and infancy through the age of 5 years. Eur J Clin Nutr 2015;69:1279–89.10.1038/ejcn.2015.117Suche in Google Scholar PubMed PubMed Central

8. Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998;21:2191–2.10.2337/diacare.21.12.2191Suche in Google Scholar PubMed

9. Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 2005;115:e500–3.10.1542/peds.2004-1921Suche in Google Scholar PubMed

10. Thorén A, Werner B, Lundholm C, Bråbäck L, Silfverdal SA. A rapid growth rate in early childhood is a risk factor for becoming overweight in late adolescence. Acta Paediatr 2015;104:1138–43.10.1111/apa.13106Suche in Google Scholar PubMed

11. Koyama S, Ichikawa G, Kojima M, Shimura N, Sairenchi T, et al. Adiposity rebound and the development of metabolic syndrome. Pediatrics 2014;133:e114–9.10.1542/peds.2013-0966Suche in Google Scholar PubMed

12. Palmer BF, Clegg DJ. The sexual dimorphism of obesity. Mol Cell Endocrinol 2015;402:113–9.10.1016/j.mce.2014.11.029Suche in Google Scholar PubMed PubMed Central

13. Djiane J, Attig L. Role of leptin during perinatal metabolic programming and obesity. J Physiol Pharmacol 2008;59(Suppl 1):55–63.Suche in Google Scholar

14. Boeke CE, Mantzoros CS, Hughes MD, Rifas-Shiman SL, Villamor E, et al. Differential associations of leptin with adiposity across early childhood. Obesity (Silver Spring) 2013;21:1430–7.10.1002/oby.20314Suche in Google Scholar PubMed PubMed Central

15. Brito N, Fonseca M, Dinis I, Mirante A. Metabolic factors in obesity. J Pediatr Endocrinol Metab 2010;23:97–100.10.1515/JPEM.2010.23.1-2.97Suche in Google Scholar

16. Koyama S, Sairenchi T, Shimura N, Arisaka O. Association between timing of adiposity rebound and body weight gain during infancy. J Pediatr 2015;166:309–12.10.1016/j.jpeds.2014.10.003Suche in Google Scholar PubMed

17. Perng W, Haji H, Berfolt MB, Rifas-Shiman SL, Kramer MS, et al. Birth size early life weight gain, and midchildhood cardiometabolic health. J Pediatr 2016;173:122–30.10.1016/j.jpeds.2016.02.053Suche in Google Scholar PubMed PubMed Central

18. Arisaka O, Ichikawa G, Koyama S, Sairenchi T. Increase in BMI from 1.5 to 3 years of age is a risk for cardiometabolic disease. Jacobs J Obes 2015;1:019.Suche in Google Scholar

Received: 2016-6-6
Accepted: 2017-1-9
Published Online: 2017-3-15
Published in Print: 2017-4-1

©2017 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Editorial
  3. Pediatric endocrinology is pediatrics is public health
  4. Original Articles
  5. Total body fat, abdominal fat, body fat distribution and surrogate markers for health related to adipocyte fatty acid-binding protein (FABP4) in children
  6. Vitamin D supplementation, the metabolic syndrome and oxidative stress in obese children
  7. Vitamin D status in Egyptian children with type 1 diabetes and the role of vitamin D replacement in glycemic control
  8. Cross-sectional analysis of universal vitamin D supplementation in former East Germany during the first year of life
  9. Ethnicity and incidence of congenital hypothyroidism in the capital of Macedonia
  10. Changes of thyroid hormonal status in patients receiving ketogenic diet due to intractable epilepsy
  11. Leptin and adiponectin levels in discordant dichorionic twins at 72 hours of age-associations with anthropometric parameters and insulin resistance
  12. Analysis of growth hormone receptor gene expression in tall and short stature children
  13. Clinical features of girls with short stature among inv (9), Turner (45, X) and control individuals
  14. Hereditary vitamin D-resistant rickets in Lebanese patients: the p.R391S and p.H397P variants have different phenotypes
  15. Associations between obesity, adverse behavioral patterns and cardiovascular risk factors among adolescent inhabitants of a Greek island
  16. Increase of body mass index (BMI) from 1.5 to 3 years of age augments the degree of insulin resistance corresponding to BMI at 12 years of age
  17. Case Reports
  18. The variable clinical phenotype of three patients with hepatic glycogen synthase deficiency
  19. Molecular defects identified by whole exome sequencing in a child with atypical mucopolysaccharidosis IIIB
  20. Clinical presentation and treatment response to diazoxide in two siblings with congenital hyperinsulinism as a result of a novel compound heterozygous ABCC8 missense mutation
  21. Cushing’s syndrome in infancy due to ectopic ACTH secretion by a sacro-coccygeal teratoma
  22. Letters to the Editor
  23. Growth-hormone deficiency in mitochondrial disorders
  24. Response to Growth hormone deficiency in mitochondrial disorders
Heruntergeladen am 8.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2016-0227/html
Button zum nach oben scrollen